|
 |
KeppraThis page contains recent news articles, when available, and an overview of Keppra but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The Food and Drug Administration approved a 1000 milligram version of the tablets, which are a generic version of UCB Pharma's Keppra, Mylan said in a ... Forbes Dad angry over way Scopwick care home death handled - Jan 1, 2010 It emerged shortly afterwards that care staff had failed to administer four doses of his twice daily prescription of 750mg of Keppra to keep his epilepsy at ... Lincolnshire Echo Mylan Inc secures FDA approval for generic antiepileptic Keppra 1000 mg - Dec 14, 2009 This product is the generic version of UCB Pharma's antiepileptic Keppra. The 1000 mg strength of Levetiracetam Tablets complements Mylan's already approved ... Trading Markets (press release) Study Eyes Epileptics' Use of Generic Drugs - Jan 4, 2010 But when the 47-year-old theater student switched to a cheaper generic version of the anticonvulsant drug Keppra this spring to save money, ... PharmaLive.com (press release) Mylan Receives Approval For Generic Version Of Antiepileptic Keppra® 1000 Mg - Dec 12, 2009 Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra®. This additional strength of Levetiracetam Tablets complements Mylan's ... Medical News Today (press release) News on Two Names - Dec 11, 2009 ...that it received approval from the Food and Drug Administration (FDA) for a new 1000-miligram dosage of UCB Pharmaceuticals' antiepileptic drug Keppra. ... TheStreet.com (subscription) Indian drug makers maintain pace of US marketing approvals - Jan 3, 2010 Cellcept; GlaxoSmithKline's blockbuster epilepsy drug, Keppra, and Wyeth's heartburn drug, Protonix, had lost patent protection in the past two years. ... Business Standard GMH to hold hearing on services, supply fees - Dec 17, 2009 Meanwhile Keppra, a medication for seizures, will be added to the permanent fee schedule for the first time, he said. Although the drugs are added to the ... Pacific Daily News Vigabatrin (Sabril®): A New Epilepsy Drug -- With Strings Attached - Dec 31, 2009 ...gabapentin (Neurontin®), lacosamide (Vimpat®), lamotrigine (Lamictal®), levetiracetam (Keppra®), oxcarbazepine (Trileptal®), pregabalin (Lyrica®), ... Medscape UCB says Crohn's study fails to prove drug - Dec 21, 2009 Parkinson's disease patch Neupro and epilesy treatment Vimpat -- after hayfever drug Zyrtec and epilepsy blockbuster Keppra lost patent protection. ... Reuters 2 Belgian drug companies in metro Atlanta have different futures - Dec 10, 2009 UCB is a leader in allergy and epilepsy with its main products being Zyrtec and Xyzal for allergy and Keppra for epilepsy. Other primary drugs include ... Atlanta Journal Constitution 2009 M&A/Alliances DOTY Nominee: GSK/UCB - Dec 11, 2009 ...the assets UCB sold to GSK include rights to the anti-epileptic Keppra and the allergy drugs Zyrec and Xyzal in certain countries in Africa, ... The IN VIVO Blog (blog) Stocks Under $10 Weekly Summary - Dec 11, 2009 The company also received approval from the Food and Drug Administration (FDA) on Friday for a new dosage of the antiepileptic drug Keppra. ... TheStreet.com (subscription) Not All Drugs Are the Same After All - Dec 18, 2009 ...as Budeprion XL 300 in one generic form), the heart medicine Toprol XL (metoprolol succinate) and the antiseizure medicine Keppra (levetiracetam). ... New York Times Gear Up For The New Year!! Sign Up For Our Newsletter!! LCRD,DLLR,HGSI,NETL ... - Dec 11, 2009 Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra(R). This additional strength of Levetiracetam Tablets complements Mylan's ... TMC Net Brivaracetam使用於局部發作型癲癇的çµ?æžœä¸?一 - Dec 15, 2009 UCB Pharma是levetiracetam（Keppraï¼‰çš„è£½é€ å» å•†ï¼Œä»–å€‘ç ”ç™¼é€™å€‹è—¥ç‰©ã€‚ ç ”ç©¶è€…å€‘é€²è¡Œäº†å…©é …å‰?瞻性ã€?多ä¸å¿ƒç ”ç©¶ï¼Œä¸€é …åœ¨åŒ—ç¾Žã€?澳洲ã€?與拉ä¸?美洲進行，å?¦ä¸€é …則在æ?洲與 ... 臺灣新浪網 Brand Name: Keppra - Nov 11, 2009 Keppra is indicated in epileptic patients as add-on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of ... Pattaya Daily News Novartis profit steady as vaccines, charges limit growth - Oct 22, 2009 Separately, Belgium's UCB (BRUSSELS:BE:UCB) said its revenue over nine months fell due to generic competition for epilepsy medication Keppra in the US, ... MarketWatch Promising early results for UCB's new products - Oct 22, 2009 As expected, revenue declined in the first nine months of 2009 compared to the same period in 2008 as a consequence of generic competition to Keppra ... Pharmacy Europe UCB announces its latest financial results - Oct 23, 2009 Its revenue declined compared to the same period in 2008, something that UCB attributes to generic competition to Keppra (levetiracetam) in the US. ... Zenopa Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide ... - Nov 3, 2009 UCB´s Keppra´s (levetiracetam) is the leading treatment for epilepsy. Despite the recent launch of two further anticonvulsants and the presence of a ... PR-Inside.com (Pressemitteilung) Forecast Insight - Epilepsy - Future market upgrade following new drug launches - Oct 26, 2009 Driven primarily by continued uptake of UCB´s market leading anticonvulsant, Keppra (levetiracetam), seven major market epilepsy revenues grew strongly at a ... PR-Inside.com (Pressemitteilung) Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32 - Oct 29, 2009 Mylan's version of UCB Pharma's Keppra®, and higher volumes, partially offset by unfavorable pricing. Mylan's Fentanyl Transdermal System (Fentanyl), ... Reuters Dr Reddy's seeks US marketing rights for `Lipitor' generic - Nov 7, 2009 Ramipril (Altace - King), Venlafaxine (Effexor -Wyeth), Lamotrigine (Lamictal - Glaxo Smith Kline), and Levetiracetam (Keppra - UCB). ... domain-B Nancy Nackaerts (UCB): “Echte cijfers over nieuwe medicijnen pas bij jaarcijfersâ€? - Oct 21, 2009 Dit werd gedeeltelijk gecompenseerd door een sterke prestatie van Keppra in Europa die een groeiend netto verkooppercentage met dubbele cijfers bleef ... Cash.be Bioformabedrijf UCB geeft voor € 150 miljoen obligaties uit - Oct 23, 2009 UCB moet de volgend jaren immers alternatieven vinden voor het epilepsiemiddel Keppra en de allergiebestrijder Zyrtec, twee bijzonder succesvolled producten ... Express.be Solvay : bénéfice en hausse au 3ème trimestre - Oct 30, 2009 Cette diminution a été partiellement compensée par les bonnes performances de Keppra en Europe, où les ventes nettes continuent d'afficher une croissance en ... Express.be UCB: CA 9 mois en baisse, confirme ses prévisions pour 2009 - Oct 21, 2009 ...de 2008 en raison de la concurrence des génériques de Keppra", son traitement contre l'épilepsie, aux Etats-Unis, a indiqué UCB dans un communiqué. ... EasyBourse.com UCB confirme ses résultats - Oct 23, 2009 Cette diminution a été partiellement compensée par les bonnes performances de Keppra en Europe, où les ventes nettes continuent d'afficher une croissance en ... Express.be Tire 20 dúvidas sobre métodos para evitar a gravidez - Nov 9, 2009 Outros anticonvulsivantes não parecem reduzir a eficácia contraceptiva, incluindo gabapentina (Neurontin®), lamotrigina (Lamictal®), levetiracetam (Keppra®) ... Terra Brasil Eurogentec a acquis AnaSpec - Oct 26, 2009 Cette diminution a été partiellement compensée par les bonnes performances de Keppra en Europe, où les ventes nettes continuent d'afficher une croissance en ... Express.be Vakbonden UCB vrezen voor collectief ontslag - Oct 28, 2009 UCB moet de volgend jaren immers alternatieven vinden voor het epilepsiemiddel Keppra en de allergiebestrijder Zyrtec, twee bijzonder succesvolled producten ... Express.be Antwerpen ongerust over besparingsplannen Bayer - Oct 28, 2009 UCB moet de volgend jaren immers alternatieven vinden voor het epilepsiemiddel Keppra en de allergiebestrijder Zyrtec, twee bijzonder succesvolled producten ... Express.be Klinisch laboratorium Medhold op zoek naar partner - Oct 27, 2009 UCB moet de volgend jaren immers alternatieven vinden voor het epilepsiemiddel Keppra en de allergiebestrijder Zyrtec, twee bijzonder succesvolled producten ... Express.be Tessenderlo Group bouwt nieuwe fabriek in Brazilië - Oct 26, 2009 UCB moet de volgend jaren immers alternatieven vinden voor het epilepsiemiddel Keppra en de allergiebestrijder Zyrtec, twee bijzonder succesvolled producten ... Express.be UCB says Keppra XR epilepsy drug approved in US - Sep 15, 2008 BRUSSELS, Sept 15 (Reuters) - Belgian pharma group UCB (UCB.BR) said on Monday that US health authorities had approved epilepsy drug Keppra XR and that it ... Reuters Keppra - Tag Story Index - USATODAY.com - Apr 3, 2007 By Lauran Neergaard, AP Medical Writer. Survivors of traumatic brain injuries -- from car-crash victims to soldiers wounded in Iraq -- face an extra hurdle ... USA Today India's Alembic in licensing deal with UCB for epilepsy drug Keppra - May 24, 2007 MUMBAI (Thomson Financial) - Indian pharma company Alembic Ltd has entered into a licensing agreement for its novel drug delivery platform for epilepsy drug ... Forbes Brussels shares higher; UCB rises on FDA approval for Keppra adult … - Aug 2, 2006 BRUSSELS (AFX) - Shares were higher midmorning, in line with other European markets, with UCB rising after the pharmaceutical company said the US Food and ... Forbes UCB says FDA approves anti-epilepsy drug Keppra for children - Jun 24, 2005 BRUSSELS (AFX) - UCB SA said the US Food and Drug Administration has approved the use of the company's anti-epilespy drug Keppra for children suffering from ... Forbes UCB posts guidance-beating results, sees Keppra sales strong thru... - Mar 14, 2006 BRUSSELS (AFX) - Belgian pharmaceuticals group UCB SA posted a guidance-beating rise in full-year net profit, soaring 130 pct to 755 mln eur, mainly on the ... Forbes UCB granted pediatric exclusivity for epilepsy drug Keppra by US FDA - Jun 6, 2008 BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB announced Friday that the US Food and Drug Administration (FDA) has granted it pediatric ... Forbes UCB completes Keppra trials for monotherapy - Sep 15, 2005 BRUSSELS (AFX) - Biopharma group UCB SA said it has completed phase III clinical trials of its anti-epilepsy drug Keppra for monotherapy and plans to file ... Forbes More European Patients With Epilepsy to Benefit From Keppra(R) - Jan 16, 2007 The European Commission (EC) has approved Keppra(R) (levetiracetam), as adjunctive therapy for the treatment of primary generalised tonic-clonic (PGTC) ... RedOrbit European Commission Approves Keppra for Use as Adjunctive Therapy … - May 15, 2006 Brussels (Belgium) - May 15, 2006 - Today UCB announced that the European Commission has approved the use of Keppra (levetiracetam) as adjunctive therapy in ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … , Otsuka sign collaboration agreement to market Keppra, Cimzia... - Jun 10, 2008 BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB SA said on Tuesday that it has signed a collaboration agreement with healthcare company ... Forbes Mylan, UCB agree to settlement over generic Keppra - Oct 4, 2007 LOS ANGELES, Oct 4 (Reuters) - Pharmaceutical drug maker Mylan Inc MYL.N said on Thursday it struck an agreement to settle pending litigation with UCB ... Reuters UK … shares higher midmorning; UCB climbs on regulator responses to... - Feb 3, 2006 Jan De Cauter, analyst at Delta Lloyd Securities, said: 'This news should have positive impact on the future sales figure of Keppra, and consequently on ... Forbes … Positive Top-Line Phase III Results for Keppra(R) as Adjunctive... - Apr 20, 2007 Brussels, Belgium - April 20, 2007 at 7:00 AM CET - UCB today announced positive top-line results from a phase III, double- blind, randomized, multi-centre, ... Web Services Journal - Web Services Journal UCB reports positive phase II results for keppra successor brivaraceta... - Sep 26, 2006 BRUSSELS (AFX) - Belgian pharmaceutical group UCB SA said that brivaracetam, the successor to its blockbuster epilepsy drug keppra, had received positive ... Forbes UCB confident Keppra drug will be a bln eur product; Cimzia dialogue ... - Jul 26, 2007 BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB SA is confident that its epileptic drug Keppra will be a billion euro product. ... Forbes Brussels shares decline midmorning; UCB positive after Keppra update - Dec 8, 2005 BRUSSELS (AFX) - Shares were lower in midmorning trade, reversing yesterday's gains after a lower close on Wall Street, but with pharmaceuticals group UCB ... Forbes Keppra promising for newly diagnosed epilepsy - Feb 6, 2007 NEW YORK (Reuters Health) - Treatment with low doses of levetiracetam, the active ingredient in the drug Keppra, appears to be effective by itself for ... Reuters UCB's Keppra gets recommendation for use in children from EU … - Aug 1, 2005 BRUSSELS (AFX) - Belgian biopharma group UCB SA said the European Medicines Agency has recommended approval of Keppra as an additional treatment for ... Forbes UCB says US FDA accepts NDA filing for Keppra XR in partial onset … - Jan 16, 2008 BRUSSELS (Thomson Financial) - UCB SA said a new drug application (NDA) for the use of its Keppra XR (levetiracetam) extended-release tablets in the ... Forbes Anti-Inflammatory Blockbuster? - Mar 22, 2006 UCB is also developing successors to its two lead drugs, Keppra and Zyrtec, ... Right now, Keppra is approved as an add-on therapy for epilepsy. ... BusinessWeek UCB raises 2008 core profit target on one-off - Oct 31, 2008 N is awaiting FDA approval to make a generic version of Keppra from November. UCB announced in August that it would cut 2000 jobs or 17 percent of its ... Reuters Brussels shares close higher, led up by Bekaert on H1 figures UPDATE - Aug 1, 2005 The biopharma group said the European Medicines Agency has recommended approval of Keppra as an additional treatment for partial-onset seizures in children ... Forbes UCB 2007 Profit Declines on Schwarz Acquisition Costs - Feb 29, 2008 UCB bought Schwarz to gain new products as its two top- selling medicines, Keppra for epilepsy and Zyrtec for allergies, face patent expirations in the US ... Bloomberg … Opinion Recommending Approval of Keppra® as Adjunctive Therapy in ... - Nov 23, 2006 Brussels, Belgium, 23 November 2006 – 7:00am CET: UCB today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ... webwire.com Keppra(R) (levetiracetam) As Adjunctive Treatment In Idiopathic … - Dec 6, 2005 According to new data, presented at a UCB sponsored Scientific Exhibit at the 59th Annual Meeting of the American Epilepsy Society in Washington, DC, US, ... Medical News Today - Medical News Today (press release) Key Approval for Keppra Offers New Treatment Option for Newly … - Aug 18, 2006 Brussels, BELGIUM, August 18, 2006 - Time 07.00 CEST: Newly diagnosed epilepsy patients in Europe with partial onset seizures can now benefit from ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset ... - Nov 5, 2008 ATLANTA, Nov. 5 /PRNewswire/ -- press release, regulated information: UCB announced today that Keppra XR(TM) offers convenient dosing for people with ... International Business Times Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam) as … - Oct 27, 2005 SMYRNA, Ga., Oct. 27 /PRNewswire/ -- UCB Pharma, Inc. today announced that it filed a supplemental new drug application (sNDA) with the US Food and Drug ... $4.95 - PR Newswire - ECNext UCB says epilepsy drug has positive trial results - Dec 3, 2007 A Phase III trial showed "Keppra XR ... extended-release tablets significantly reduced partial onset seizure frequency when administered as adjunctive ... Reuters AAN: Keppra Reduces Seizures Induced by Brain Tumors - Apr 13, 2005 By Ed Susman,. MIAMI BEACH, April 13-The anticonvulsant medication Keppra (levetiracetam) reduces seizures induced by malignant brain tumors and may even ... MedPage Today UCB says Q1 meets its expectations, revenue down - May 15, 2008 Net sales of epilepsy drug Keppra grew by a double-digit percentage as did revenues of allergy drug Xyzal and cough medicine Tussionex. ... Reuters India FDA Approves Keppra(R) (Levetiracetam) as Adjunctive Therapy in the … - Aug 23, 2006 BRUSSELS, BELGIUM -- August 23, 2006 -- Today UCB announced that the US Food & Drug Administration (FDA) has approved the use of Keppra® (levetiracetam) as ... DG News Preliminary 2006 UCB SA Earnings Conference Call - Final. - Feb 28, 2007 Also the Keppra successes and a number of other new products, ... Let's spend some time on Keppra. Net sales of Keppra rose by EUR201 million or 36%, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Belgian drugmaker UCB to cut 2,000 jobs worldwide - Aug 28, 2008 In UCB's case, this requires moving from reliance on older drugs such as hayfever medicine Zyrtec and epilepsy drug Keppra, which face patent expiry in the ... Reuters => HUGIN NEWS/FDA Approves Keppra® Intravenous Formulation <= - Feb 8, 2006 Brussels (BELGIUM) August 2, 2006 - 7:00 am CET - Today UCB announced that the US Food and Drug Administration (FDA) has approved Keppra® (levetiracetam) ... FinanzNachrichten.de UCB CEO says targets FY profit at least in line with year earlier... - Jun 14, 2005 He reiterated that full-year sales of the group's blockbuster anti-epileptic drug Keppra are expected to grow by more than 20 pct. ... Forbes Scientists Seek Early Interventions For Epilepsy - Apr 4, 2007 Among the efforts: pilot studies to see if the newer seizure-treating drugs Topamax or Keppra might actually prevent epilepsy if they're taken immediately ... Wired News Taking epilepsy drugs - Dec 4, 2008 1] If you take other drugs, your doctor may recommend you take gabapentin (brand name Neurontin) or levetiracetam (brand name Keppra). ... guardian.co.uk … - UCB receives positive opinion for the use of Keppra® as Monotherap... - Mar 7, 2006 UCB has undertaken a comprehensive clinical trial program for Keppra® and this ... Data from this trial demonstrated that Keppra® was non-inferior to ... euronext.com Keppra Approved for US Epilepsy Patients with One of the Most … - Mar 20, 2007 FDA approves Keppra for primary generalized tonic-clonic seizures in adults and children aged 6 and older Brussels, Belgium - March 20, 2007 - 8:30 pm CET ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Studies show Keppra® reduces seizure frequency in patients with brain... - Apr 25, 2005 The anti-epileptic drug Keppra® (levetiracetam) significantly reduced seizures and was well tolerated in patients with brain tumors, according to research ... i-newswire.com For Patients With Partial-Onset Seizures - New Keppra XR Data... - Dec 10, 2008 UCB has announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XRâ„¢ (levetiracetam) extended-release tablets comparing ... Medical News Today - Medical News Today (press release) A Key Regulatory Milestone for Keppra(R) - Jul 3, 2006 UCB today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion to ... Genetic Engineering News - Genetic Engineering News (press release) Studies show Keppra(reg) reduces seizure frequency in patients with … - Apr 24, 2005 The anti-epileptic drug Keppra(reg) (levetiracetam) significantly reduced seizures and was well tolerated in patients with brain tumors, according to ... Medical News Today - Medical News Today (press release) Altabax, Keppra. - May 1, 2007 The Food and Drug Administration approved Altabax (retapamulin ointment 1%) for topical treatment of impetigo caused by susceptible strains of ... Free with registration - Pediatric News - AccessMyLibrary.com FDA grants pediatric exclusivity for UCB's Keppra - Jun 8, 2008 UCB has announced that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra (levetiracetam). The decision was based on ... News-Medical.net UCB: IV Keppra Gets EU Regulatory Nod - Apr 27, 2006 In addition to receiving European approval for IV Keppra, the EMEA has also recommended the drug for use in juvenile myoclonic epilepsy. ... RedOrbit Levetiracetam (Keppra): Dosage, Side Effects, and Interactions - Oct 29, 2007 Levetiracetam (Keppra) may be used to help control partial seizures in adults. It is usually used with, not instead of, other antiepileptic medicines ... WebMD Epilepsy; Data supports use of Keppra in children resistant to AED … - Jan 3, 2005 2005 JAN 3 - (NewsRx.com & NewsRx.net) -- New data from pediatric clinical trials show that Keppra significantly reduces seizure frequency and in some cases ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Keppra® Approved For US Epilepsy Patients With One Of The Most … - Mar 29, 2007 The US Food and Drug Administration (FDA) has approved UCB's leading anti-epileptic drug Keppra® (levetiracetam), as adjunctive therapy in the treatment of ... Medical News Today - Medical News Today (press release) Mylan shares dip as the company cuts profit guidance - May 9, 2008 Other opportunities include the possible launch of generic Paxil, a depression treatment, and generic Keppra, an epilepsy drug. Boston Globe … trial results for new epilepsy treatment Keppra (levetiracetam)... - Sep 18, 2005 Paediatric clinical trial results of the new epilepsy treatment Keppra ... "Keppra was effective and well-tolerated by children in the study, ... Medical News Today - Medical News Today (press release) EU Approves Keppra(R) For Use As Adjunctive Therapy In The Treatment … - May 17, 2006 UCB announced that the European Commission has approved the use of Keppra(R) (levetiracetam) as adjunctive therapy in the treatment of myoclonic seizures in ... Medical News Today - Medical News Today (press release) Antiepileptic Drug Keppra (Levetiracetam) Reduces Migraine Pain in … - Apr 15, 2005 By Ed Susman. MIAMI, FL -- April 15, 2005 -- Migraine attacks in children can be controlled with the antiepileptic drug levetiracetam (Keppra), ... DG News Phase III Results For Keppra® As Adjunctive Therapy For Partial Onset... - Apr 24, 2007 UCB today announced positive top-line results from a phase III, double-blind, randomized, multi-centre, placebo-controlled study evaluating the efficacy and ... Medical News Today - Medical News Today (press release) … US FDA Grants Pediatric Exclusivity for UCB's Keppra(R). - PR... - Jun 6, 2008 US FDA Grants Pediatric Exclusivity for UCB's Keppra(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Myoclonic Epilepsy; US FDA approves Keppra as adjunctive therapy... - Sep 18, 2006 2006 SEP 18 - (NewsRx.com) -- UCB announced that the US Food & Drug Administration (FDA) has approved the use of Keppra (levetiracetam) as adjunctive ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones FDA Approvals: Tygacil, Keppra, Enbrel - Jun 30, 2005 June 30, 2005 — The US Food and Drug Administration (FDA) has approved tigecycline for the treatment of complicated intra-abdominal infections and ... Medscape Keppra Approved for Additional Indication - Mar 27, 2007 The FDA has approved an additional indication for UCB Pharma's Keppra (levetiracetam) tablets and oral solution. The new indication provides for the use of ... Facts and Comparisons Business Update; US FDA approves Keppra Intravenous Formulation - Aug 29, 2006 2006 AUG 29 - (NewsRx.com) -- UCB announced that the US Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection 500mg/5mL ... Pay-Per-View - Science Letter - Factiva, from Dow Jones … Approvable Letter for Keppra (levetiracetam) Intravenous Administra... - Feb 3, 2006 ..."This new Keppra formulation will be of help to patients and physicians in ... When approved by the regulatory authorities, Keppra will become the first of ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com International Approvals: Keppra, Menactra, Aromasin - May 22, 2006 May 22, 2006 — The European Commission has approved a new indication for levetiracetam, allowing its use as adjunctive therapy for juvenile myoclonic ... Medscape Business Update; US FDA approves Keppra Intravenous Formulation - Sep 1, 2006 2006 SEP 1 - (NewsRx.com) -- UCB announced that the US Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection 500mg/5mL (100mg/mL) ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Epilepsy; Keppra Pregnancy Registry launched to monitor drug's impact... - Jan 4, 2005 2005 JAN 4 - (NewsRx.com & NewsRx.net) -- UCB Pharma, Inc., announced the creation of the North American Keppra (levetiracetam) Pregnancy Registry, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Epilepsy; Data supports use of Keppra in children resistant to AED … - Jan 7, 2005 2005 JAN 7 - (NewsRx.com & NewsRx.net) -- New data from pediatric clinical trials show that Keppra significantly reduces seizure frequency and in some cases ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones Press Release: FDA Approves Keppra(R) Intravenous Formulation. - PR … - Aug 2, 2006 FDA Approves Keppra(R) Intravenous Formulation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research More European Patients With Epilepsy To Benefit From Keppra(reg) - Jan 20, 2007 The European Commission (EC) has approved Keppra(reg) (levetiracetam), as adjunctive therapy for the treatment of primary generalised tonic-clonic (PGTC) ... Medical News Today - Medical News Today (press release) Press Release: UCB's Anti-Epileptic Keppra(R) Meets Primary End-Point... - Sep 15, 2005 UCB's Anti-Epileptic Keppra(R) Meets Primary End-Point in Monotherapy Trial. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research MM&M All-Stars Small Pharma Marketing Team of the Year: Keppra (UCB … - Jan 1, 2008 Since last year, when UCB, Inc. let users of its antiepileptic Keppra speak ... Keppra achieved $729 million in sales through September, a 43% rise over the ... Medical Marketing & Media - Medical Marketing and Media … : Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam)... - Oct 27, 2005 Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment for Myoclonic Seizures. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: Keppra, Tag-It Cystic Fibrosis Kit.(New & Approved) - Family... - Sep 1, 2005 Keppra, Tag-It Cystic Fibrosis Kit.(New & Approved) ... find Family Practice News articles. Keppra (levetiracetam, UCB Pharma) The Food and Drug ... Pay-Per-View - Family Practice News - HighBeam Research Positive Clinical Trial Results for Keppra(R) as Adjunctive Therapy... - Oct 31, 2005 UCB announced positive clinical trial results from a study evaluating Keppra(R) (levetiracetam) as adjunctive treatment in adult and paediatric patients ... Medical News Today - Medical News Today (press release) … Approves Use of UCB's Anti-Epileptic Keppra As Adjunctive Therapy... - Sep 22, 2005 BRUSSELS, Belgium, Sept. 22, 2005 (PRIMEZONE) -- Today UCB announced that the European Commission has approved the use of Keppra(r) (levetiracetam) in the ... RedOrbit Article: Altabax, Keppra. - Pediatric News | HighBeam Research - FREE... - May 1, 2007 Altabax, Keppra. ... find Pediatric News articles. DAMIAN McNAMARA, MIAMI BUREAU Altabax (retapamulin ointment 1%, GlaxoSmith Kline) ... Pay-Per-View - Pediatric News - HighBeam Research … Commission Approves Use of Anti-Epileptic Keppra(R) as Adjunctive ... - Sep 22, 2005 European Commission Approves Use of Anti-Epileptic Keppra(R) as Adjunctive Therapy in Children Four Years of Age and Older With Partial-Onset Seizures. from ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Video: Keppra XR(TM) Approved in the US - PR … - Sep 15, 2008 Video: Keppra XR(TM) Approved in the US from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Keppra XR(TM) Data Highlight Its Role for Patients... - Dec 9, 2008 New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research EU Commission Approves Keppra(R) as Adjunctive Therapy in Children … - Sep 26, 2005 Today UCB announced that the European Commission has approved the use of Keppra(R) (levetiracetam) in the European Union, as adjunctive therapy in the ... Medical News Today - Medical News Today (press release) Press Release: FDA Grants Priority Review to Keppra(R) for Use in … - Feb 17, 2005 FDA Grants Priority Review to Keppra(R) for Use in Childhood Epilepsy. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Keppra XR(TM) Offers Convenient Dosing For People … - Nov 5, 2008 Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research FDA Approves Keppra® as Adjunctive Therapy in the Treatment of … - Aug 23, 2006 Keppra® now approved to treat a generalized seizure type in adult and adolescent ... approval for Keppra® for the treatment of a generalized seizure type ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Schwarz Reports Full-Year Net, Forecasts 2007 Profit - Feb 26, 2007 Brussels-based UCB, whose best-selling Keppra epilepsy treatment loses patent protection in 2008, offered to buy Schwarz last year for about 4.4 billion ... Bloomberg Keppra IV formulation approved.(PRODUCTS)(Brief article) - Oct 1, 2006 The Food and Drug Administration has approved levetiracetam injection 500 mg/5 mL for use as adjunctive therapy in the treatment of partial-onset seizures ... $4.95 - Internal Medicine News - ECNext European Commission Approves Keppra® for Use as Adjunctive Therapy … - May 15, 2006 European Commission has approved the use of Keppra® (levetiracetam) ... "Keppra® has over one million patient years' experience and continues ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Lung cancer drugs will cost more - Jun 17, 2005 The other drugs hit by the stand-off between the Government and drug companies are Topamax and Keppra, prescribed to counter epileptic seizures, ... Sydney Morning Herald Market Winners & Losers: Goldman Sachs, Genworth - Nov 11, 2008 The company is still riding the wave from the release of Keppra, a generic epilepsy drug. The drug maker closed up near $10 at closing bell on Tuesday. ... FOXBusiness FDA Approves UCB's Keppra® for Use in Childhood Epilepsy - Jun 27, 2005 UCB announced today that the US Food and Drug Administration (FDA) has approved the company's anti-epilepsy drug Keppra® (levetiracetam) as add-on therapy ... i-newswire.com FDA Grants Priority Review to Keppra(R) for Use in Childhood Epilepsy. - Feb 17, 2005 ATLANTA, Feb. 17 /PRNewswire/ -- UCB Pharma, Inc. has been granted a priority review for the supplemental new drug application (sNDA) seeking approval of ... $4.95 - PR Newswire - ECNext New Data on the Use of Keppra® (levetiracetam) as Adjunctive Treatment... - Dec 6, 2005 ...seizures became free from all types of seizures when Keppra® ... show that Keppra® significantly reduced PGTC seizures. The ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Press Release: FDA Approves UCB's Keppra(R) for Use in Childhood … - Jun 24, 2005 FDA Approves UCB's Keppra(R) for Use in Childhood Epilepsy. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Keppra.(New & Approved) | Article from Pediatric News | HighBeam … - Aug 1, 2005 Keppra.(New & Approved) ... find Pediatric News articles. (levetiracetam, UCB Pharma) The Food and Drug Administration approved a new pediatric indication . Pay-Per-View - Pediatric News - HighBeam Research Consumer complaints about Keppra - Dec 22, 2008 After I was given Keppra, in Brandywine Hospital, Coatesville Pa. I immediately had a seizure. I was never given this drug before for seizures, ... Consumer Affairs Growing Demand from Epilepsy Patients for Seizure Response Dogs … - Nov 1, 2005 Keppra(R) is available in 250, 500 and 750 mg tablets and a grape-flavored ... Keppra(R) dosing must be individualized according to renal function status. ... Free with registration - PR Newswire - AccessMyLibrary.com … company submits applications for antiepileptic and intravenous... - Jan 18, 2005 Keppra is indicated as adjunctive therapy in the treatment of partial onset ... Keppra is available in 250, 500 and 750 mg tablets and a grape-flavored (100 ... Pay-Per-View - Science Letter - Factiva, from Dow Jones UCB: Two European Regulatory Milestones for Keppra® - Apr 26, 2006 European Commission has approved the use of Keppra® (levetiracetam) ... positive opinion, recommending the approval of Keppra® as adjunctive ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Business Update; US FDA approves Keppra Intravenous Formulation - Aug 28, 2006 2006 AUG 28 - (NewsRx.com) -- UCB announced that the US Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection 500mg/5mL ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones … company submits applications for antiepileptic and intravenous... - Jan 21, 2005 Keppra is indicated as adjunctive therapy in the treatment of partial onset ... Keppra is available in 250, 500 and 750 mg tablets and a grape-flavored (100 ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … company submits applications for antiepileptic and intravenous... - Jan 22, 2005 Keppra is indicated as adjunctive therapy in the treatment of partial onset ... Keppra is available in 250, 500 and 750 mg tablets and a grape-flavored (100 ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones UCB's Keppra cleared in USA as adjunct therapy. - Sep 4, 2006 UCB's Keppra cleared in USA as adjunct therapy. Brussels, Belgium-based biopharmaceutical company UCB says that the US Food and Drug Administration has ... $9.94 - Pharma Marketletter - Alacra Store |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |